| Line Item | 2023-07-31 | Y/Y |
|---|---|---|
| R&D Expense | $15.3M | +91.2% |
| SG&A Expense | $7.9M | +9.2% |
| Operating Income | -$23.3M | -52.2% |
| Interest Expense | $979 | +0.0% |
| Pre-tax Income | -$20.3M | +24.4% |
| Net Income | -$20.3M | +24.4% |
| EPS (Basic) | -$1.30 | +24.9% |
| EPS (Diluted) | -$1.30 | +24.9% |
| Line Item | 2023-07-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21.3M | -48.2% |
| Accounts Receivable | $19K | -21.7% |
| Current Assets | $26.9M | -36.4% |
| Total Assets | $27.2M | -36.2% |
| Current Liabilities | $1.8M | +91.4% |
| Stockholders' Equity | -$3.8M | -136.6% |
| Line Item | 2023-07-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.7M | -90.2% |
| Financing Cash Flow | $4.0M | +205.7% |